Brazil’s national medicines regulatory agency ANVISA has delayed proposed new rules on good manufacturing practice (GMP) for pharmaceutical excipients after …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

